Title: Philippe Langella: Innovator in Medical Research
Introduction: Philippe Langella is a notable inventor based in Vélizy, France. He has made significant contributions to the field of medical research, particularly in the treatment of various diseases. Although he currently holds no granted patents, his work continues to influence the scientific community.
Latest Patent Applications: Philippe Langella's latest patent applications include two significant inventions. The first application is titled "Kynurenine Aminotransferase and Products Thereof for the Treatment of Arthritic Diseases." This invention relates to the treatment of arthritic diseases, such as rheumatoid arthritis, using a kynurenine aminotransferase, a living recombinant bacterium genetically modified to express and secrete said enzyme, and/or a product of this enzyme, which includes xanthurenic acid or its derivatives. The second application is "Kynurenine Aminotransferase and Products Thereof for the Treatment of Inflammatory Bowel Diseases." This invention focuses on treating inflammatory bowel diseases with the same kynurenine aminotransferase and its products.
Conclusion: Philippe Langella's innovative work in medical research showcases his dedication to advancing treatments for serious health conditions. His contributions, although not yet patented, hold promise for future developments in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.